NASDAQ · PNTG
The Pennant Group, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PNTG: Nov 4, 2026
The Pennant Group, Inc. Common Stock is estimated to report earnings on 11/04/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $0.28. The reported EPS for the same quarter last year was $0.25.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.28 | $0.28 | $0.28 | 1 |
| Dec 2026 | $0.31 | $0.31 | $0.31 | 1 |
| Mar 2027 | $0.28 | $0.28 | $0.28 | 1 |
| Jun 2027 | $0.34 | $0.34 | $0.34 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · MarketBeat · The Motley Fool- Zacks · Sep 21, 12:00 PM EDTAre You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great ChoiceDoes The Pennant Group, Inc. (PNTG) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Sep 17, 3:16 AM EDTThe Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?The Pennant Group (PNTG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks · Sep 14, 12:00 PM EDTAll You Need to Know About The Pennant Group (PNTG) Rating Upgrade to BuyThe Pennant Group (PNTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Sep 2, 9:25 AM EDTCan Ensign Group's Operating Model Drive Growth Beyond Acquisitions?ENSG's decentralized model is driving organic growth through higher occupancy, stronger clinical results and improved productivity across its facilities.
- Zacks · Aug 27, 10:20 AM EDTHere's Why Ensign Group Stock Remains a Buy for InvestorsEnsign Group's rising occupancy, acquisitions and real-estate growth support its outlook, while reimbursement and cost pressures remain risks.
- MarketBeat · Aug 19, 7:30 AM EDTAmid Legal Risks, This Company Is Still Rated a BuyWhen investors look for stocks riding the aging of America, they might look at hospital chains, pharmacy benefit managers, or dividend-paying healthcare REITs. What few might expect is PACS Group (NYSE: PACS), a skilled nursing operator whose stock fell more than 80% in a year
- Zacks · Aug 7, 11:40 AM EDTOPCH vs. PNTG: Which Stock Is the Better Value Option?OPCH vs. PNTG: Which Stock Is the Better Value Option?
- MarketBeat · Aug 7, 4:04 AM EDTThe Pennant Group Q2 Earnings Call Highlights3 Small Cap Stocks That May Someday be Large CapsThe Pennant Group (NASDAQ:PNTG) reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company to raise its full-year outloo
- Zacks · Aug 5, 8:35 PM EDTThe Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue EstimatesThe Pennant Group (PNTG) delivered earnings and revenue surprises of +9.09% and +3.47%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 4, 1:26 PM EDTIs BTSG a Buy as Rapid Growth Collides With Its Premium Valuation?BrightSpring's broad-based growth and margin gains strengthen its outlook, but a premium valuation leaves little room for execution missteps.
- Zacks · Aug 3, 5:45 PM EDTAddus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue EstimatesAddus HomeCare (ADUS) delivered earnings and revenue surprises of +2.37% and +0.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Jul 14, 4:15 PM EDTWhat This Pennant Group Insider Sale Means as Home Health Revenue Surged 43%The transaction involved 3,159 shares with an estimated value of ~$131,000 realized on July 10, 2026.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for The Pennant Group, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.